Osteostrand
Payments companies reported to CMS as associated with Osteostrand. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Osteostrand, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Osteostrand
These are the largest totals companies reported as associated with Osteostrand. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Scott Boden | Atlanta, GA | Orthopaedic Surgery of The Spine | $100,887.53 |
| Christopher Digiovanni | Providence, RI | Foot and Ankle Surgery | $58,041.36 |
| Michael Bauer | Castle Rock, CO | Blood Banking & Transfusion Medicine | $34,500.00 |
| Raymond Hah | Los Angeles, CA | Orthopaedic Surgery of The Spine | $2,571.31 |
| Harvinder Sandhu | New York, NY | Orthopaedic Surgery of The Spine | $265.01 |
| Donny Melton | Denver, CO | Neurological Surgery | $225.22 |
| David Yam | Brush Prairie, WA | Neurological Surgery | $217.39 |
| Cary Templin | Joliet, IL | Orthopaedic Surgery | $216.60 |
| Joseph Laratta | Louisville, KY | Orthopaedic Surgery of The Spine | $212.74 |
| Jamal Shillingford | Larkspur, CA | Orthopaedic Surgery of The Spine | $212.74 |
Prescribed Osteostrand?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.